QDDresearch

US Foods Holding Corp. USFD

Consumer StaplesFood & Drug RetailingUnited States of America

Last close 103.61 USD on Nov 1, 2026, +37.6% year to date

Quant rating

Quant rating B Rank 22 of 124 in Consumer Staples
  1. Growth A 15 of 124
  2. Valuation C 73 of 124
  3. Quality B 32 of 124
  4. Revisions C 54 of 124
  5. Momentum A 11 of 124

Wall Street consensus Buy (1.80)Average target 114.73 USD +10.7%

Historical valuation

Multiples use consensus estimates for the next twelve months. The dashed line is the 5-year average.

Growth and profitability fiscal year ends December 31

Growth and profitability by fiscal year
202520242023202220215Y avg
Revenue (mil)39,42437,87735,59734,05729,487–
Revenue growth4.1%6.4%4.5%15.5%28.8%11.5%
EPS (basic, normalized)3.983.152.632.141.55–
EPS growth26.3%19.8%22.9%38.1%––
Gross margin17.4%17.3%17.3%16.1%15.8%16.8%
Net margin1.7%1.3%1.4%0.7%0.4%1.1%
ROE15.3%10.6%10.9%6.0%3.9%9.4%
Balance sheet, last quarter
Cash & short-term investments (mil)56.0
Current ratio1.14x
Long-term debt (mil)5,087
Net debt (mil)5,349
Total equity (mil)4,279
Net debt / equity1.25x
Net debt / EBITDA2.77x

Estimates and valuation

Consensus estimates and implied multiples
Sales (mil)EBITDA (mil)EPS
Fiscal yearMean est.GrowthEV/SalesMean est.GrowthEV/EBITDAMean est.GrowthP/E
2025 actual 39,424+4.1%0.7x 1,932+11.2%14.4x 3.98+26.3%26.0x
2026 41,474+5.2%0.7x 2,111+9.3%13.2x 4.76+19.7%21.7x
2027 43,116+4.0%0.6x 2,304+9.2%12.0x 5.54+16.2%18.7x
2028 45,480+5.5%0.6x 2,517+9.2%11.0x 6.31+13.9%16.4x

Estimate revisions

Change in consensus estimates over 1, 3 and 6 months
SalesEPS
Fiscal yearEstimate (mil)1M3M6MEstimate1M3M6M
202641,474−0.1%+0.1%−0.3%4.76−0.3%+1.5%−0.2%
202743,116−0.1%+0.1%−0.3%5.54−0.1%+1.5%−0.8%
202845,480−0.1%+0.3%−0.4%6.31−3.3%+0.3%−3.1%

Earnings surprises EPS beat in 3 of the last 4 quarters

Reported results versus consensus, last 10 fiscal quarters
Quarter endedMar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales reported (mil)8,9499,7099,7289,4919,35110,08210,1919,8009,61010,532
Sales mean (mil)8,9159,6239,7189,4909,38210,17810,1789,9059,64710,461
Surprise+0.4%+0.9%+0.1%0.0%−0.3%−0.9%+0.1%−1.1%−0.4%+0.7%
EPS reported0.540.930.850.840.681.191.071.040.781.43
EPS mean0.530.930.830.800.691.131.031.000.811.36
Surprise+1.5%+0.2%+2.4%+4.6%−2.0%+5.1%+3.5%+4.3%−3.6%+5.1%

Peer comparison Food & Drug Retailing

Peers in the same industry group, by market capitalization
CompanyMarket capNet debt/EBITDANet marginP/BFY1 P/EFY2 P/EFY1 EV/EBITDAFY2 EV/EBITDA
USFD US Foods Holding Corp.22.4B2.77x1.7%5.24x21.7x18.7x13.2x12.0x
WMT Walmart Inc.979.9B1.16x3.1%9.99x42.9x38.3x20.9x19.3x
SYY Sysco Corporation40.8B2.67x2.1%14.88x16.4x15.4x10.9x10.4x
KR Kroger Co39.4B1.86x0.7%6.81x12.9x12.2x6.7x6.6x
CASY Caseys General Stores Inc25.1B1.29x4.1%6.14x31.8x29.0x16.6x15.3x
PFGC Performance Food Group Company15.6B3.48x0.5%3.16x17.5x14.9x10.1x9.2x
Mean2.20x2.0%7.70x23.9x21.4x13.1x12.2x
Median2.27x1.9%6.48x19.6x17.0x12.0x11.2x

Technical analysis

  • 1M+10.6%
  • 3M+2.1%
  • 1Y+39.4%
  • 3Y+180.6%

Financial statements in millions of USD

Income statement, US Foods Holding Corp., fiscal years, most recent first
202520242023202220212020
Total revenue39,42437,87735,59734,05729,48722,885
Cost of revenue32,56031,34329,44928,56524,83219,166
Gross profit6,8646,5346,1485,4924,6553,719
Selling, general & administrative expenses5,5255,3175,0274,7934,1253,678
Research & development––––––
Depreciation/amortization95.088.086.070.073.079.0
Interest expense (income), operating––––––
Unusual expense (income)45.016439.035.056.039.0
Other operating expenses000000
Operating income1,199965996594401−77.0
Net interest income (expense)−305−315−324−255−213−238
Gain (loss) on sale of assets––––––
Other non-operating income (expense)4.0−6.06.022.026.021.0
Net income before taxes898644678361214−294
Provision for taxes22215017296.050.0−68.0
Minority interest––––––
Equity in affiliates––––––
U.S. GAAP adjustment––––––
Net income before extraordinary items676494506265164−226
Extraordinary items––––––
Net income676494506265164−226
EBIT, normalized1,3301,1921,104731438140
EBITDA, normalized1,7921,6301,4991,103816562
Basic EPS, normalized3.983.152.632.141.55–

Disclaimer

The financial data presented in this report is delayed and obtained from sources QDD Research believes to be reliable, including stock exchanges, SEDAR, and EDGAR. However, no representation or warranty is made as to the accuracy, completeness, or timeliness of the information. QDD Research accepts no liability for any errors, omissions, or financial losses arising from the use of this data.

This report is generated using a fully systematic and quantitative approach. All factor scores and the overall quant rating (ranging from D to A+) are derived from algorithmic models and are based solely on objective financial metrics. These scores are intended for informational purposes only and should not be interpreted as investment advice or a recommendation to buy, sell, or hold any securities.

QDD Research is not a registered investment advisor or broker-dealer and does not provide personalized financial advice. The content is not tailored to the specific investment goals, financial situation, or risk profile of any individual investor. We strongly encourage readers to consult with a licensed broker or investment advisor before making any investment decisions based on the information contained in this report.

Live quote provided by TradingView. Report data updated Nov 1, 2026 after market close.